Repro Med Systems
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $8,179 | $8,430 | $8,197 | $7,185 |
Gross Profit | 5,185 | 5,479 | 4,871 | 4,102 |
EBITDA | -1,247 | -974 | -1,729 | -1,969 |
EBIT | -1,475 | -1,192 | -1,961 | -2,197 |
Net Income | -1,580 | -988 | -1,935 | -7,466 |
Net Change In Cash | 8,179 | 8,430 | 8,197 | 7,185 |
Free Cash Flow | -1,983 | -137 | -479 | 888 |
Cash | 8,806 | 10,458 | 10,820 | 11,482 |
Basic Shares | 45,851 | 45,811 | 45,712 | 45,669 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $28,517 | $27,896 | $23,490 | $24,176 |
Gross Profit | 16,708 | 15,368 | 13,769 | 14,936 |
EBITDA | -9,399 | -10,193 | -6,566 | 1,611 |
EBIT | -10,269 | -10,780 | -7,029 | 1,192 |
Net Income | -13,741 | -8,661 | -4,562 | -1,212 |
Net Change In Cash | 28,517 | 27,896 | 23,490 | 24,176 |
Cost of Revenue | -7,926 | -1,980 | 21,444 | |
Free Cash Flow | -5,707 | -8,206 | -4,694 | -1,804 |
Cash | 11,482 | 17,408 | 25,334 | 27,315 |
Basic Shares | 45,601 | 45,002 | 44,385 | 41,929 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.01 |
2024-06-30 | -$0.02 |
2024-03-31 | -$0.02 |
2023-12-31 | -$0.03 |
